CUSIP 09077V100 · who reports it, how much, and how much it matters to them
26 of the 720 hedge fund managers we track reported shares of BioAge Labs, Inc. (Nasdaq: BIOA) on Form 13F for 30 June 2026. Between them they reported USD 352m. The largest position belongs to Cormorant Asset Management, at USD 59m. The manager with the most riding on it is Octagon Capital Advisors, where it is 3.9% of the reported book.
Compiled from SEC Form 13F filings · Hedge Fund Intelligence, PPLI.com · updated
Form 13F is filed by the manager and covers all of its accounts, so a position here belongs to the firm, not to any one fund. Not investment advice.
A list of every manager in our coverage that reported this share at the end of the quarter, taken from the filings themselves. Short positions and options are not in it.
Taken from each manager's Form 13F for 30 June 2026. A manager appears here if it reported the shares themselves; positions held only through options are left out.
The bar and the percentage show how much of the manager's reported 13F book the position makes up. Each name opens that manager's largest fund on PPLI.com, where the rest of its book is listed.
| # | Manager | Value reported | Share of its book |
|---|---|---|---|
| 1 | Cormorant Asset Management1 fund on PPLI.com | USD 59m | 3.0% |
| 2 | Sofinnova Investments1 fund on PPLI.com | USD 56m | 2.9% |
| 3 | Octagon Capital Advisors1 fund on PPLI.com | USD 43m | 3.9% |
| 4 | Ra Capital Management1 fund on PPLI.com | USD 41m | 0.4% |
| 5 | Polar Capital LLP26 funds on PPLI.com | USD 26m | 0.1% |
| 6 | Braidwell12 funds on PPLI.com | USD 25m | 0.9% |
| 7 | Orbimed Advisors1 fund on PPLI.com | USD 18m | 0.3% |
| 8 | D. E. Shaw & Co.15 funds on PPLI.com | USD 18m | 0.0% |
| 9 | Balyasny Asset Management25 funds on PPLI.com | USD 17m | 0.0% |
| 10 | Walleye Capital8 funds on PPLI.com | USD 8.7m | 0.0% |
| 11 | Adage Capital Management1 fund on PPLI.com | USD 7.4m | 0.0% |
| 12 | Millennium Management6 funds on PPLI.com | USD 5.5m | 0.0% |
| 13 | Sphera Funds Management1 fund on PPLI.com | USD 5.2m | 0.7% |
| 14 | Yiheng Capital Management1 fund on PPLI.com | USD 4.2m | 1.4% |
| 15 | Renaissance Technologies13 funds on PPLI.com | USD 4.1m | 0.0% |
| 16 | Burkehill Global Management5 funds on PPLI.com | USD 2.5m | 0.1% |
| 17 | Citadel Advisors32 funds on PPLI.com | USD 1.9m | 0.0% |
| 18 | Squarepoint Ops7 funds on PPLI.com | USD 1.7m | 0.0% |
| 19 | Two Sigma Investments35 funds on PPLI.com | USD 1.5m | 0.0% |
| 20 | Boothbay Fund Management2 funds on PPLI.com | USD 1.5m | 0.0% |
| 21 | Persistent Asset Partners10 funds on PPLI.com | USD 913,000 | 0.3% |
| 22 | Voloridge Investment Management6 funds on PPLI.com | USD 866,000 | 0.0% |
| 23 | Marshall Wace LLP84 funds on PPLI.com | USD 778,000 | 0.0% |
| 24 | Wexford Capital8 funds on PPLI.com | USD 632,000 | 0.1% |
| 25 | Verdad Advisers6 funds on PPLI.com | USD 426,000 | 0.4% |
| 26 | Engineers Gate Manager1 fund on PPLI.com | USD 344,000 | 0.0% |
A large manager can hold a great deal of a share and barely notice it. This table turns the question round and ranks managers by how much of their own book the position takes up.
| # | Manager | Value reported | Share of its book |
|---|---|---|---|
| 1 | Octagon Capital Advisors | USD 43m | 3.9% |
| 2 | Cormorant Asset Management | USD 59m | 3.0% |
| 3 | Sofinnova Investments | USD 56m | 2.9% |
| 4 | Yiheng Capital Management | USD 4.2m | 1.4% |
| 5 | Braidwell | USD 25m | 0.9% |
| 6 | Sphera Funds Management | USD 5.2m | 0.7% |
| 7 | Verdad Advisers | USD 426,000 | 0.4% |
| 8 | Ra Capital Management | USD 41m | 0.4% |
| 9 | Orbimed Advisors | USD 18m | 0.3% |
| 10 | Persistent Asset Partners | USD 913,000 | 0.3% |
BioAge Labs, Inc. trades under the symbol BIOA on the Nasdaq. Its CUSIP, the code used on Form 13F, is 09077V100.
26 of the 720 hedge fund managers PPLI.com tracks reported BioAge Labs, Inc. shares on Form 13F for 30 June 2026. The largest reported positions were held by Cormorant Asset Management (USD 59m), Sofinnova Investments (USD 56m), Octagon Capital Advisors (USD 43m), Ra Capital Management (USD 41m) and Polar Capital LLP (USD 26m).
26 managers in our coverage reported it, and between them they run 309 funds with a file on PPLI.com. The count is of managers, because Form 13F is filed by the firm and not by each fund.
Octagon Capital Advisors, where the position was 3.9% of the reported 13F book at 30 June 2026.
No. Form 13F reports long positions in U.S.-listed shares and options. Short positions are not disclosed in it.
Positions are taken by PPLI.com from Form 13F filings with the U.S. Securities and Exchange Commission for the quarter shown. They are reported by each manager, cover all of its accounts and may have changed since. PPLI.com has no relationship with BioAge Labs, Inc. or with the managers listed.
Nothing here is investment, tax or legal advice, a recommendation, or an offer or solicitation to buy or sell any security. To report an error, write to the editor.
Read our Privacy Policy before submitting. Share only the information needed to describe your question; do not include medical records or account credentials.